Active Ingredient History

NOW
  • Now
Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

Australia

$367.5930 - $1470.3487

United States

$858.8900 - $4867.2000
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

abx-egf | abx-egf mab | abx-egf monoclonal antibody | amg 954 | e7.6.3 | immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal abx-egf heavy chain), disulfide with human monoclonal abx-egf light chain, dimer | l01xc08 | panitumumab | panitumumab antibody, human | vectibix

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue